NCT04033770

Brief Summary

Comparison of water-perfused (WP) and air-charged (AC) catheters for invasive urodynamic investigation (UDI) regarding consistency, features and artifacts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
490

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
1.5 years until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2022

Completed
Last Updated

February 14, 2022

Status Verified

February 1, 2022

Enrollment Period

1 year

First QC Date

March 26, 2019

Last Update Submit

February 11, 2022

Conditions

Keywords

Urodynamic investigationLower urinary tract dysfunctionWater-perfused catheterAir-charged catheter

Outcome Measures

Primary Outcomes (1)

  • Artefact susceptibility of the measurement systems

    Number of Artifacts impairing the quality/interpretability of the urodynamic examination

    During the urodynamic investigation

Secondary Outcomes (6)

  • Subjective perception of pain and discomfort (on a visual analog scale) between the measurement systems

    During the urodynamic investigation

  • Incidence of side effects: number and intensity/severity (mild/moderate/severe) of AEs and SAE for the following categories during and for 7 days after the urodynamic investigation using an air-charged vs. water-perfused measurement system

    Once during urodynamic investigation and 7 days thereafter

  • Difference in volumetric during urodynamic investigation using an air-charged vs. water-perfused measurement system

    During the urodynamic investigation

  • Difference in Compliance [mL/cmH2O] during urodynamic investigation using an air-charged vs. water-perfused measurement system

    During the urodynamic investigation

  • Difference in Pressure changes during urodynamic investigation using an air-charged vs. water-perfused measurement system

    During the urodynamic investigation

  • +1 more secondary outcomes

Study Arms (2)

Air-charged measurement system

ACTIVE COMPARATOR

UDI (same session repeat filling cystometry and pressure flow study) according to "Good Urodynamic Practice" recommended by the ICS but using an air-charged instead of a water-filled measurement system.

Other: Urodynamic investigation

Water-perfused measurement system

ACTIVE COMPARATOR

UDI (same session repeat filling cystometry and pressure flow study) according to "Good Urodynamic Practice" recommended by the ICS.

Other: Urodynamic investigation

Interventions

Urodynamic investigation using an air-charged measurement system

Air-charged measurement system

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patients with LUTD
  • Age: minimum 18 years
  • Informed consent
  • Competent German language skills

You may not qualify if:

  • Age \<18 years
  • Pregnancy or breast feeding (see chapter 3.6.)
  • Symptomatic UTI
  • Individuals especially in need of protection
  • No informed consent
  • Patients incapable to follow the trial, e.g. because of language problems, psychiatric disorders, dementia and so on.
  • Earlier participation in this clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinik Balgrist

Zurich, Switzerland

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2019

First Posted

July 26, 2019

Study Start

February 1, 2021

Primary Completion

February 11, 2022

Study Completion

February 11, 2022

Last Updated

February 14, 2022

Record last verified: 2022-02

Locations